Use of radiation in treatment of central nervous system juvenile xanthogranulomatosis

Pediatr Hematol Oncol. 2012 Aug;29(5):440-5. doi: 10.3109/08880018.2012.691151. Epub 2012 Jun 19.

Abstract

Juvenile xanthogranulomatosis (JXG) represents a subset of non-Langerhan cell histiocytosis that typically manifests in younger children with skin lesions. Unresectable central nervous system (CNS) disease is difficult to treat. We describe the case of a 13-year-old successfully treated with adjuvant radiation therapy for symptomatic intracranial and leptomeningeal JXG. An extensive literature review was performed to identify all previous CNS JXG cases utilizing radiation, of which six of eight total patients demonstrated temporary or long-term improvement of neurologic disease. This suggests that radiation should be considered in cases unresponsive to conventional treatment options.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / radiotherapy*
  • Humans
  • Male
  • Radiotherapy, Adjuvant / methods
  • Xanthogranuloma, Juvenile / diagnosis
  • Xanthogranuloma, Juvenile / radiotherapy*